亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

A Method of Developing Single Molecule DNA Nanoparticles as Diagnostic and Therapeutic Agents

技术优势
Offers a powerful therapeutic platform based on DNA—a molecule approved for in vivo human use. Avoids the conjugation chemistries typically associated with conferring target specificity, biocompatibility, and drug incorporation. Provides a multifunctional platform for integrating many cancer therapeutic techniques.
详细技术说明
Leveraging DNA’s inherently unique properties and ease of synthesis, a UC San Diego researcher has developed a methodology for the construction of large libraries of DNA nanoparticles and a process for the iterative selection of particles with desired properties. When coupled with DNA’s other structural, functional, chemical, and informatic properties, this technology permits the efficient customization of multifunctional particles for biomedical and therapeutic use. Leveraging DNA’s near anti-body specificity, practically non-toxic biocompatibility, and other desired properties, this technology provides a powerful approach for designing custom targeted therapeutics and diagnostic probes in a variety of applications.
*Abstract

Current nanoparticle-based approaches for treating disease include constructs composed of polymer, silica, gold nanoparticles, liposomes, or carbon nanotubes, to name a few. These structures are typically coated with a variety of functionalizing entities such as polyethylene glycol (to increase biocompatibility) and may be conjugated to various targeting peptides, antibodies, small molecules, or some form of therapeutic. A major disadvantage of these approaches is the need to develop complex conjugation chemistries for targeting specificity, biocompatibility, and drug incorporation by nanoparticles. Another limitation of this approach is the frequent requirement of additional clinical testing of the new nanoparticle coatings and entities.

DNA itself provides a simpler nanoparticle approach. One of the most thoroughly characterized molecules with regard to physical structure, chemistry, and modification, DNA may be employed as a scaffold for the integration of varying entities due to its well defined ability to base-pair hybridize. Also, DNA particles may be easily loaded with DNA-binding chemotherapy agents.

*IP Issue Date
Nov 25, 2014
*Principal Investigation

Name: Bradley Messmer

Department:

附加资料
Patent Number: US20120263783A1
Application Number: US13502729A
Inventor: Messmer, Bradley T.
Priority Date: 20 Oct 2009
Priority Number: US20120263783A1
Application Date: 28 Jun 2012
Publication Date: 18 Oct 2012
IPC Current: A61K00317088 | A61K0009127 | A61P003500 | C07H002104 | C12P001934 | C12Q000168 | C40B003004 | C40B004006 | B82Y000500 | B82Y004000
US Class: 424450 | 4350061 | 4350915 | 43509151 | 506009 | 506016 | 514044R | 5360231 | 977773 | 977840
Assignee Applicant: The Regents of the University of California
Title: SINGLE MOLECULE NUCLEIC ACID NANOPARTICLES
Usefulness: SINGLE MOLECULE NUCLEIC ACID NANOPARTICLES
Summary: In liposome and in pharmaceutical composition for treating cancer (claimed); and for specific targeting, drug delivery to cancer cells, and diagnostics.
Novelty: Nanoparticle useful for treating cancer comprises single-strand nucleic acid containing concatameric sequences, where the concatameric sequences encodes aptamer
主要类别
诊断/治疗
细分类别
癌症/肿瘤
申请号码
8895242
其他

State Of Development

This platform technology is offered exclusively or nonexclusively for U.S. and/or worldwide territories. A commercial sponsor for potential future research is sought.


Related Materials

Dr. Bradley T. Messmer is an assistant project scientist at the Rebecca and John Moores Cancer Center at UC San Diego. Professor Messmer received his B.S. from the Colorado School of Mines in 1993 and a Ph.D. from Rockefeller University in 2000.
Marciniak JY, AC Kummel, SC Esener, MJ Heller, BT Messmer (2008) Coupled rolling circle amplification loop-mediated amplification for rapid detection of short DNA sequences. BioTechniques 45(3):275–280.


Tech ID/UC Case

19246/2008-237-0


Related Cases

2008-237-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备